Danielle Bar

Dynamic and academically accomplished physician with dual expertise in Medicine and Computer Science. Proven track record as the first author on multiple peer-reviewed studies published in prestigious journals, including the Journal of the American Academy of Dermatology (JAAD). Recognized for contributions as a peer reviewer for leading international dermatology journals and as a reliable consultant for statistical analyses in clinical and epidemiologic research. Committed to advancing dermatologic care through evidence-based medicine, academic leadership, and impactful research initiatives.

• Bar D, Baum S, Segal Z, Barzilai A, Druyan A, Lidar M. Early initiation of hydroxychloroquine in CLE to prevent progression to SLE. JAAD, 2025.
• Bar D, Baum S, Druyan A, et al. Prognostic disparities of pyoderma gangrenosum. Ann Dermatol Venereol, 2025.
• Bar D, Beberashvili I. Role of wound debridement in pyoderma gangrenosum. Wound Repair Regen, 2024.
• Bar D, Lidar M, Baum S, et al. Methotrexate for PsA prevention in psoriasis. Joint Bone Spine, 2024.
• Ozeri DJ, Bar D, et al. Renal outcomes in FMF amyloidosis. Semin Arthritis Rheum, 2025.
• Sherman S, Slama R, Bar D, et al. T1D and Hidradenitis Suppurativa Comorbidity. J Clin Med, 2025.
• Sherman S, Duskin-Bitan H, Bar D, et al. Vitiligo and melasma association. Indian J Dermatol, 2025.
• Giat E, Livneh A, Lidar M, Bar D, Gilad Dor L, Azem S, Ben Zvi I, Druyan A. Non-canonical manifestations of FMF in homozygous M694V MEFV genotype: Insights from a large patient cohort. Semin Arthritis Rheum. 2025; 65:152821. doi:10.1016/j.semarthrit.2025.152821
• Giat E, Livneh A, Ben-Zvi I, Druyan A, Bar D, Ozeri DJ, Almoznino G, Lidar M. A single dose of anakinra for arresting familial Mediterranean fever attacks: a proof-of-concept study. Clin Exp Rheumatol. 2025 Oct;43(10):1735-1741. doi: 10.55563/clinexprheumatol/cj61ub. Epub 2025 Oct 23. PMID: 41133353.
• Bar D. Early Initiation of Hydroxychloroquine in Cutaneous Lupus Erythematosus to Prevent Progression to Systemic Lupus Erythematosus: A Long-term Follow-up Study. Oral presentation at the Annual Meeting of the Israeli Society of Dermatology and Venereology, 2025.
• Oral Presentation: Global Vitiligo Foundation Annual Scientific Symposium, AAD Meeting, San Diego, March 2025
• Presenter: Annual Rheumatology Conference (×2)
• Participant: American Academy of Dermatology (AAD) Annual Meeting, Orlando

• Clinical Internship (Stáž), Assaf Harofeh Medical Center, Israel
• Expected: December 2025 – August 2026

Conferences and Presentations

• First author of several original research articles published in high-impact journals including JAAD.
• Reviewer for leading dermatology journals worldwide.
• Provides statistical consultation for clinical, translational, and epidemiologic research projects.

Conferences and Presentations

1. Bar D. Early Initiation of Hydroxychloroquine in Cutaneous Lupus Erythematosus to Prevent Progression to Systemic Lupus Erythematosus: A Long-term Follow-up Study. Oral presentation at the Annual Meeting of the Israeli Society of Dermatology and Venereology, 2025.

2. Oral Presentation: Global Vitiligo Foundation Annual Scientific Symposium, AAD Meeting, San Diego, March 2025

3. Presenter: Annual Rheumatology Conference (×2) Participant: American Academy of Dermatology (AAD) Annual Meeting, Orlando